SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 46.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,172 shares of the exchange traded fund’s stock after selling 3,596 shares during the period. Stratos Wealth Partners LTD.’s holdings in SPDR S&P Biotech ETF were worth $338,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Demars Financial Group LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $280,309,000. BlueCrest Capital Management Ltd bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $138,051,000. Mirae Asset Securities USA Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 66.7% in the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after buying an additional 600,000 shares during the period. Bessemer Group Inc. lifted its stake in SPDR S&P Biotech ETF by 4.0% during the first quarter. Bessemer Group Inc. now owns 1,432,066 shares of the exchange traded fund’s stock worth $116,141,000 after purchasing an additional 55,232 shares during the period. Finally, RA Capital Management L.P. bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $110,615,000.

SPDR S&P Biotech ETF Trading Down 2.7%

Shares of XBI stock opened at $85.91 on Wednesday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47. The firm’s fifty day moving average price is $82.17 and its two-hundred day moving average price is $84.56. The firm has a market capitalization of $5.04 billion, a P/E ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.